PCVX
Price
$33.09
Change
-$1.00 (-2.93%)
Updated
Jun 25 closing price
Capitalization
4.27B
47 days until earnings call
STOK
Price
$11.81
Change
+$0.30 (+2.61%)
Updated
Jun 25 closing price
Capitalization
644.79M
46 days until earnings call
Interact to see
Advertisement

PCVX vs STOK

Header iconPCVX vs STOK Comparison
Open Charts PCVX vs STOKBanner chart's image
Vaxcyte
Price$33.09
Change-$1.00 (-2.93%)
Volume$741.3K
Capitalization4.27B
Stoke Therapeutics
Price$11.81
Change+$0.30 (+2.61%)
Volume$629.23K
Capitalization644.79M
PCVX vs STOK Comparison Chart in %
Loading...
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
PCVX vs. STOK commentary
Jun 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCVX is a Buy and STOK is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 26, 2025
Stock price -- (PCVX: $33.09 vs. STOK: $11.81)
Brand notoriety: PCVX and STOK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: PCVX: 39% vs. STOK: 95%
Market capitalization -- PCVX: $4.27B vs. STOK: $644.79M
PCVX [@Biotechnology] is valued at $4.27B. STOK’s [@Biotechnology] market capitalization is $644.79M. The market cap for tickers in the [@Biotechnology] industry ranges from $312.97B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

PCVX’s FA Score shows that 0 FA rating(s) are green whileSTOK’s FA Score has 1 green FA rating(s).

  • PCVX’s FA Score: 0 green, 5 red.
  • STOK’s FA Score: 1 green, 4 red.
According to our system of comparison, STOK is a better buy in the long-term than PCVX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

PCVX’s TA Score shows that 5 TA indicator(s) are bullish while STOK’s TA Score has 3 bullish TA indicator(s).

  • PCVX’s TA Score: 5 bullish, 3 bearish.
  • STOK’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, PCVX is a better buy in the short-term than STOK.

Price Growth

PCVX (@Biotechnology) experienced а -0.93% price change this week, while STOK (@Biotechnology) price change was +2.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.95%. For the same industry, the average monthly price growth was +31.79%, and the average quarterly price growth was +15.79%.

Reported Earning Dates

PCVX is expected to report earnings on Aug 12, 2025.

STOK is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+1.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PCVX($4.27B) has a higher market cap than STOK($645M). STOK YTD gains are higher at: 7.072 vs. PCVX (-59.577). STOK has higher annual earnings (EBITDA): 40.3M vs. PCVX (-512.62M). PCVX has more cash in the bank: 1.67B vs. STOK (357M). STOK has less debt than PCVX: STOK (2.35M) vs PCVX (87.2M). STOK has higher revenues than PCVX: STOK (191M) vs PCVX (0).
PCVXSTOKPCVX / STOK
Capitalization4.27B645M662%
EBITDA-512.62M40.3M-1,272%
Gain YTD-59.5777.072-842%
P/E RatioN/A14.40-
Revenue0191M-
Total Cash1.67B357M468%
Total Debt87.2M2.35M3,709%
FUNDAMENTALS RATINGS
STOK: Fundamental Ratings
STOK
OUTLOOK RATING
1..100
77
VALUATION
overvalued / fair valued / undervalued
1..100
54
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
41
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
27
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
PCVXSTOK
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
80%
Bearish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
85%
MACD
ODDS (%)
Bearish Trend 1 day ago
75%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
81%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
82%
Bullish Trend 1 day ago
84%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 4 days ago
86%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 9 days ago
84%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
88%
Aroon
ODDS (%)
Bullish Trend 1 day ago
87%
Bullish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
PCVX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
STOK
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OBCHX8.23N/A
N/A
Oberweis China Opportunities
SSSYX457.43N/A
N/A
State Street Equity 500 Index K
SUVAX12.22N/A
N/A
PGIM Quant Solutions Large-Cap Val A
IARYX17.26N/A
N/A
Invesco Real Estate Y
BBTIX12.70-0.07
-0.55%
Bridge Builder Tax Managed Intl Eq

PCVX and

Correlation & Price change

A.I.dvisor indicates that over the last year, PCVX has been loosely correlated with ORKA. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if PCVX jumps, then ORKA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PCVX
1D Price
Change %
PCVX100%
-2.93%
ORKA - PCVX
43%
Loosely correlated
-1.11%
DYN - PCVX
41%
Loosely correlated
-1.98%
DNLI - PCVX
40%
Loosely correlated
+0.35%
COGT - PCVX
39%
Loosely correlated
-2.35%
STOK - PCVX
38%
Loosely correlated
+2.61%
More

STOK and

Correlation & Price change

A.I.dvisor indicates that over the last year, STOK has been loosely correlated with IMNM. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if STOK jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STOK
1D Price
Change %
STOK100%
+2.61%
IMNM - STOK
52%
Loosely correlated
-2.69%
IDYA - STOK
52%
Loosely correlated
+1.06%
RNA - STOK
50%
Loosely correlated
+0.10%
QTTB - STOK
49%
Loosely correlated
-1.89%
TRML - STOK
48%
Loosely correlated
+0.30%
More